当前位置:首页 - 行情中心 - 东诚药业(002675) - 财务分析 - 资产负债表

东诚药业

(002675)

  

流通市值:106.68亿  总市值:118.33亿
流通股本:7.43亿   总股本:8.25亿

资产负债表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
流动资产:
货币资金697,376,537.69755,972,381.28770,179,007.66861,339,732.94
应收票据及应收账款942,784,583.2927,454,486.75938,551,532.6911,819,718.6
其中:应收票据12,482,457.2415,041,474.939,361,054.828,335,727
应收账款930,302,125.96912,413,011.82929,190,477.78903,483,991.6
应收款项融资13,061,988.138,782,652.1116,747,973.8512,677,498.85
预付款项26,994,547.1127,160,841.3419,237,846.5423,587,068.84
其他应收款合计14,079,067.1712,486,659.7810,724,895.168,408,602.03
应收股利1,097,550---
存货605,047,336.63646,221,273.48635,729,750.03733,044,932.71
一年内到期的非流动资产3,397,370.323,374,653.981,503,259.17860,186.07
其他流动资产30,991,885.537,654,028.3555,433,523.5579,094,089.5
流动资产平衡项目0000
流动资产合计2,474,529,699.312,567,648,523.382,633,124,956.352,741,387,566.71
非流动资产:
债权投资39,229,835.538,568,709.2936,895,678.2336,810,496.99
长期应收款1,520,945.921,520,945.923,251,775.064,720,864.73
长期股权投资207,435,530.34211,285,607.8211,201,976.69223,188,145.77
其他权益工具投资106,200,000106,200,000106,200,000106,200,000
投资性房地产20,047,566.5519,831,354.5996,119.1396,119.13
固定资产1,712,063,403.461,730,899,116.521,406,613,630.011,417,042,309.33
在建工程589,012,623.86567,907,007.76870,224,137.96780,118,261.7
使用权资产126,005,629.9236,091,555.2812,220,026.2314,600,146.31
无形资产247,132,338.94252,539,244.52211,829,531.41209,104,227.16
开发支出279,610,812.24265,690,610.52305,243,842.39279,254,441.89
商誉2,500,181,476.342,500,809,824.612,542,387,276.942,549,742,647.92
长期待摊费用146,144,502.3797,332,150.3347,710,545.1236,486,298.25
递延所得税资产99,917,289.1694,889,299.7178,676,372.8874,165,773.4
其他非流动资产137,947,936.49143,464,046.21178,234,282.61195,969,911.53
非流动资产平衡项目0000
非流动资产合计6,212,449,891.096,067,029,473.066,010,785,194.665,927,499,644.11
资产平衡项目0000
资产总计8,686,979,590.48,634,677,996.448,643,910,151.018,668,887,210.82
流动负债:
短期借款288,123,011.43448,879,586.83419,838,715.95493,657,239.56
应付票据及应付账款595,358,686.43588,406,696.41580,632,949.69614,912,781.28
其中:应付票据389,243,191.89393,667,747.52410,240,559.64445,468,494.31
应付账款206,115,494.54194,738,948.89170,392,390.05169,444,286.97
预收款项243,882.87376,957.757,799.9324,865.31
合同负债103,262,680.75105,632,249.25117,979,735.43123,174,934.61
应付职工薪酬88,442,409.66116,490,184.6196,017,731.0687,912,090.5
应交税费78,638,587.1970,018,035.6274,172,869.0269,431,748.27
其他应付款合计298,686,458.76330,347,243.92253,970,467276,869,925.95
其中:应付利息4,963,516.525,160,165.995,411,074.895,365,520.34
应付股利37,727,605.7153,580,427.6821,874,783.7534,046,776.79
一年内到期的非流动负债75,078,603.1673,987,713.73111,468,553.11117,655,867.5
其他流动负债14,513,907.8319,817,452.68,495,397.1812,145,830.99
流动负债平衡项目0000
流动负债合计1,542,348,228.081,753,956,120.721,662,584,218.341,796,085,283.97
非流动负债:
长期借款317,138,046.69301,857,994.42308,441,134.83271,987,244.8
租赁负债122,183,457.9433,882,639.015,117,293.016,314,305.68
长期应付款1,094,021,310.94958,202,692.18940,744,451.3921,220,355.21
预计负债2,219,888.252,219,888.252,219,888.252,219,888.25
递延收益192,374,440.1195,685,123.73237,789,248.65233,222,937.89
递延所得税负债16,813,302.0317,405,583.2417,803,653.3417,272,348.34
非流动负债平衡项目0000
非流动负债合计1,744,750,445.951,509,253,920.831,512,115,669.381,452,237,080.17
负债平衡项目0000
负债合计3,287,098,674.033,263,210,041.553,174,699,887.723,248,322,364.14
所有者权益(或股东权益):
实收资本(或股本)824,595,705824,595,705824,595,705824,595,705
资本公积1,988,379,422.191,998,256,195.261,999,160,938.532,003,409,648.94
其他综合收益14,966,678.7714,841,578.2810,720,020.3650,857.54
盈余公积279,244,326.85279,244,326.85240,596,430.83240,596,430.83
未分配利润1,388,238,365.731,363,506,842.541,426,426,917.821,371,348,604.47
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计4,495,424,498.544,480,444,647.934,501,500,012.544,440,001,246.78
少数股东权益904,456,417.83891,023,306.96967,710,250.75980,563,599.9
股东权益平衡项目0000
股东权益合计5,399,880,916.375,371,467,954.895,469,210,263.295,420,564,846.68
负债和股东权益合计8,686,979,590.48,634,677,996.448,643,910,151.018,668,887,210.82
公告日期2025-04-302025-02-272024-10-292024-08-31
审计意见(境内)标准无保留意见
TOP↑